Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
01:11:17 min
CLEAR ALL
The FDA is helping to speed up the process of researching and approving psilocybin, a hallucinogenic substance in magic mushrooms, to treat major depressive disorder (MDD).
The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.
1
My first encounter with ketamine did not go well.
2
Sizing up the commercial and therapeutic prospects for the psychedelic revival.
In the deep space of the psychedelic experience exists a teaching on unity principle and belonging with the earth.
The psychedelic revolution has arrived—yet psychologists still have major gaps in knowledge about going on a shrooms trip in the name of mental health.
Many people have a spiritual experience on psychedelics. How they make meaning of it could be influenced by the metaphysical beliefs of their therapists.
French photographer Mathias de Lattre's project "Mother's Therapy" examines the relationship between mental illness and psychedelic therapies.
People of color are dealing with racism all the time, in large and small ways, and even dealing with racism in healthcare, even dealing with racism in therapy.
Could there be one factor that links together conflict, climate change, racism, anxiety and eating disorders?